[go: up one dir, main page]

BE894376A - PHARMACEUTICAL PREPARATION - Google Patents

PHARMACEUTICAL PREPARATION

Info

Publication number
BE894376A
BE894376A BE0/208995A BE208995A BE894376A BE 894376 A BE894376 A BE 894376A BE 0/208995 A BE0/208995 A BE 0/208995A BE 208995 A BE208995 A BE 208995A BE 894376 A BE894376 A BE 894376A
Authority
BE
Belgium
Prior art keywords
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
BE0/208995A
Other languages
French (fr)
Inventor
Ranchhordas Sheth Prabhakar
J L Tossounian
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BE894376A publication Critical patent/BE894376A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE0/208995A 1981-09-14 1982-09-13 PHARMACEUTICAL PREPARATION BE894376A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30149881A 1981-09-14 1981-09-14

Publications (1)

Publication Number Publication Date
BE894376A true BE894376A (en) 1983-03-14

Family

ID=23163649

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/208995A BE894376A (en) 1981-09-14 1982-09-13 PHARMACEUTICAL PREPARATION

Country Status (11)

Country Link
JP (1) JPS5857315A (en)
AT (1) AT385199B (en)
BE (1) BE894376A (en)
BG (1) BG60526B2 (en)
CH (1) CH652025A5 (en)
DE (1) DE3232873A1 (en)
FR (1) FR2512676B1 (en)
GB (1) GB2105590B (en)
IT (1) IT1158048B (en)
MX (1) MX9203173A (en)
NL (1) NL190746C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3659B (en) 1991-01-23 1996-01-25 Isis Pharma Gmbh Orally adminsterable drugs for the treatmentof central dopamine deficiency conditions

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6143108A (en) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd Medicinal drug and its preparation
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
EP0198769A3 (en) * 1985-04-12 1987-09-02 Forest Laboratories, Inc. Floating sustained release therapeutic compositions
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
SE460947B (en) * 1986-08-26 1989-12-11 Lejus Medical Ab A MULTIPLE-UNIT DOS COMPOSITION OF L-DOPA
DE3642668A1 (en) * 1986-12-13 1988-06-23 Kamprad Joachim Painkillers for people
DE3875716D1 (en) * 1987-12-31 1992-12-10 Asta Medica Ag SYNERGISTIC COMBINATION OF DECARBOXYLASE INHIBITORS AND L-DOPA PELLETS.
DE69017915T2 (en) * 1989-10-26 1995-07-27 Nippon Shinyaku Co Ltd PREPARATION FOR THE STOMACH.
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
SE9203594D0 (en) * 1992-11-30 1992-11-30 Christer Nystroem DISPERSA SYSTEM MEDICINAL PRODUCT
CA2175225C (en) * 1993-10-29 2004-09-21 Keith Graeme Hutchison Gelatin capsule fill able to foam
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
JPH09504286A (en) * 1993-10-29 1997-04-28 レキット アンド コールマン プロダクツ リミテッド Effervescent gelatin capsule filling
US5840756A (en) * 1995-07-21 1998-11-24 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition of L-DOPA ester
AU2003282603A1 (en) * 2002-10-11 2004-05-04 Depomed Development Ltd Gastro-retentive levodopa delivery form
DE102004039196B4 (en) 2004-08-12 2008-07-31 Dr.Kamprad Kg New formulation for L-tryptophan
DE102010023828A1 (en) * 2010-06-15 2011-12-15 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Pharmaceutical preparation containing entacapone, levodopa and carbidopa
DE102014003744A1 (en) 2014-03-10 2015-09-10 Laboratorium für Lebensmittelwissenschaft (FPE) - Eidgenössische Technische Hochschule Zürich (ETH) Product for oral administration to humans or animals with microstructured encapsulated ingredients, and apparatus for making such a product, and method of making the same
DE102022103658A1 (en) 2022-02-16 2023-08-17 Joachim Kamprad Drug composition containing L-tryptophan (L-Try) and L-5-hydroxytryptophan (5-HTP) and a peripheral degradation inhibitor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH409996A (en) * 1961-06-16 1966-03-31 Hoffmann La Roche Process for the preparation of substituted hydrazines
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
ZA713877B (en) * 1970-07-24 1972-03-29 Hoffmann La Roche Pharmaceutical composition
DE2305209A1 (en) * 1972-02-14 1973-08-23 Hoffmann La Roche PHARMACEUTICAL PREPARATION
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3659B (en) 1991-01-23 1996-01-25 Isis Pharma Gmbh Orally adminsterable drugs for the treatmentof central dopamine deficiency conditions

Also Published As

Publication number Publication date
CH652025A5 (en) 1985-10-31
ATA341582A (en) 1987-08-15
GB2105590A (en) 1983-03-30
IT1158048B (en) 1987-02-18
AT385199B (en) 1988-02-25
FR2512676A1 (en) 1983-03-18
MX9203173A (en) 1992-07-01
JPS5857315A (en) 1983-04-05
NL8203343A (en) 1983-04-05
NL190746C (en) 1994-08-01
BG60526B2 (en) 1995-07-28
DE3232873A1 (en) 1983-03-31
FR2512676B1 (en) 1987-01-23
IT8223147A0 (en) 1982-09-07
JPH0341447B2 (en) 1991-06-24
NL190746B (en) 1994-03-01
GB2105590B (en) 1985-05-30

Similar Documents

Publication Publication Date Title
MC1782A1 (en) PHARMACEUTICAL PREPARATION
FI822191A0 (en) PHARMACEUTICAL BLANDING
DK68392A (en) PHARMACEUTICAL PREPARATION CONTAINING CEFUROXIMAXETIL
DK237884D0 (en) PHARMACEUTICAL PREPARATION
PT73686A (en) PHARMACEUTICAL FORMULATION
DK481585D0 (en) PHARMACEUTICAL PREPARATION CONTAINING ANTHRACYCLING LYCOSIDES
BE894376A (en) PHARMACEUTICAL PREPARATION
DK345682A (en) PHARMACEUTICAL EXPIENSES
FI832197L (en) PHARMACEUTICAL BLANDING
IT8248677A0 (en) PHARMACEUTICAL FORMULATIONS
DE3279806D1 (en) CORPUSCULES CONTAINING MEDICAMENTS
FI810056L (en) PHARMACEUTICAL FORM
DK58983D0 (en) PHARMACEUTICAL PREPARATION
DK152219C (en) AZOPIGMENT PREPARATIONS
DK288686D0 (en) PHARMACEUTICAL PREPARATIONS
FR2598617B1 (en) PHARMACEUTICAL COMPOSITION
DK32182A (en) LIQUID BIOCID PREPARATION
FI831687A0 (en) PHARMACEUTICAL BLANDNINGAR VILKA INNEHAOLLER FLERE AKTIVA BESTAONDSDELAR
DK314283D0 (en) PHARMACEUTICAL PREPARATIONS
FR2503161B1 (en) NOVEL FLUOROPROSTACYCLINS, THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION
MC1371A1 (en) PHARMACEUTICAL PREPARATIONS
MC1372A1 (en) PHARMACEUTICAL PREPARATIONS
NL193821B (en) Pharmaceutical preparation.
BE891013A (en) PHARMACEUTICAL COMPOSITIONS
IT8249072A0 (en) PHARMACEUTICAL COMPOSITIONS

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: F. *HOFFMANN-LA ROCHE A.G.

Effective date: 20020913